Digital Therapeutic (DTx) Market by Application (Prediabetes, Nutrition, Care, Diabetes, CVD, CNS, CRD, MSD, GI, Substance Abuse, Rehabilitation), Sales Channel (B2C, Patient, Caregiver, B2B, Providers, Payer, Employer, Pharma) – Global forecasts to 2025

2020-03-20
Price :
Published : Mar-2020
No. of Pages : 166

“Growing incidence of preventable chronic diseases and the need to control healthcare costs are the key factors driving the growth of the digital therapeutics market.”

The global digital therapeutics market is projected to reach USD 6.9 billion by 2025 from USD 2.1 billion in 2020, at a CAGR of 26.7% during the forecast period. Growth in this market is mainly driven by the growing incidence of preventable chronic diseases, the need to control healthcare costs, and rising investments in digital therapeutics. On the other hand, a lack of awareness and access to digital therapeutics programs in developing countries, resistance from traditional healthcare providers, and unstable payment models are challenging the growth of this market.

Treatment/care-related applications segment accounted for the largest share of the digital therapeutics market in 2019

Based on application, the digital therapeutics market is segmented into preventive and treatment/care-related applications.Rising healthcare costs, the growing prevalence of chronic diseases, and the ability of digital therapeutics to provide cost-effective solutions are some factors responsible for driving the market for treatment/care-related digital therapeutics applications.

Diabetes segment is expected to dominate the market

Based on the type of treatment/care-related application, the digital therapeutics market is further segmented into diabetes, CNS disorders, chronic respiratory diseases, musculoskeletal disorders, cardiovascular diseases, smoking cessation, medication adherence, gastrointestinal disorders, substance use disorders & addiction management, rehabilitation & patient care, and other treatment/care-related applications. The diabetes segment accounted for the largest share of the digital therapeutics market. The large share of this segment is attributed to the growing prevalence of diabetes across the globe. In addition, government initiatives to reduce the burden of diabetes using digital health are responsible for the large share of this segment.

B2B segment is expected to grow at the highest CAGR during the forecast period.

Based on the sales channel, the digital therapeutics market is segmented into business-to-customer (B2C) and business-to-business (B2B). The B2B segment is the largest and fastest-growing segment of the digital therapeutics market. The high preference of pharmaceutical companies to integrate digital therapeutics with their drug products to offer adherence services is a key factor driving the growth of this segment. Furthermore, rising awareness among payers, employers, and providers about the benefits of digital therapeutics has also supported the market growth.

North America to be the largest and the fastest-growing regional market

North America, which comprises the US and Canada, forms the largest market for digital therapeutics. The US is home to a plethora of digital therapeutics start-ups. In addition, government initiatives to support technological advancements, improvements in the reimbursement structure for digital therapeutics, and the increasing investments in digital therapeutics are responsible for the high growth of digital therapeutics in North America.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type: Tier 1 (50%), Tier 2 (30%), and Tier 3 (20%)
  • By Designation: C-level (75%), D-level (15%), and Others (10%)
  • By Region: North America (70%), Europe (20%), APAC (7%), and the RoW (3%)

List of Companies Profiled in the Report

  • Noom (US)
  • Livongo Health (US)
  • Omada Health (US)
  • WellDoc (US)
  • Pear Therapeutics (US)
  • Proteus Digital Health (US)
  • Propeller Health (US)
  • Akili Interactive Labs (US)
  • Better Therapeutics (US)
  • Happify (US)
  • Kaia Health (Germany)
  • Mango Health (US)
  • Click Therapeutics (US)
  • Canary Health (US)
  • Wellthy Therapeutics (India)
  • Cognoa (US)
  • Ayogo Health (Canada)
  • Mindstrong Health (US)
  • 2Morrow (US)
  • Ginger (US)

Research Coverage:

This report provides a study of the digital therapeutics market. It aims at estimating the size and future growth potential of the market across different segments, such as sales channel, application, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of revenue numbers for the overall digital therapeutics market and its sub segments. This report will also help stakeholders understand the competitive landscape, gain insights to position their business,and make suitable go-to-market strategies. It will also enable stakeholders to gauge the pulse of the market and provide them with information on the key market drivers, restraints, challenges, and opportunities.

Filed in: Medical Device
Publisher : marketsandmarkets
More Reports
Title Price Buy Now

European Medical Devices Market by Type (Diagnostic Imaging, Endoscopy Equipment, Respiratory Care, Cardiac Monitoring Devices, Haemodialysis Devices, Ophthalmic Devices, Anesthesia Monitoring), End User (Hospitals, Home-care) – Forecast to 2025

“The European Medical Device market is projected to grow at a CAGR of 4.7 % between 2020 and 2025.” The European medical devices market is projected to reach USD 61.4 billion by 2025 from an estimated USD 48.9 billion in 2020, at a CAGR of 4.7% during the forecast period. Factors such as the rising geriatric population, large and established medical technology industry, increasing number of surgical procedures, growing need for cost-containment in the healthcare industry, and the availability of funding for research and product innovation are driving the growth of this market. However, fiscal unsustainability due to wasteful spending might hamper the market growth to a certain extent. “Orthopedic device segment to have the largest share during the forecast period.” The ort......
$5650

Centesis Catheters Market by Type (Small and Large bore), Procedure (Paracentesis, Thoracentesis, Amniocentesis), Application (Diagnosis, Therapeutics and Palliative care), End user (Hospitals, Ambulatory surgery centers), Region – Global Forecast to 2025

“Global centesis catheters market is projected to grow at a CAGR of 6.8%” The global centesis catheters market is projected to reach USD 633 million by 2025 from USD 426 million in 2019, growing at a CAGR of 6.8% from 2019 to 2025. The key factors driving the growth of this market include the rising target patient population (particularly patients suffering from cancer, TB, and cardiovascular diseases), growing preference for image-guided centesis procedures, and the increasing evidence for the efficacy of centesis procedures for target diseases. However, premium product pricing and medical complexities associated with centesis procedures are some of the major factors that are expected to restrain the growth of this market in the coming years. “Small-bore centesis catheters seg......
$5650

Veterinary PoC Diagnostics Market by Product (Imaging Systems, Analyzers, Reagents), Technology (Immuno & Molecular Diagnostics), Application (Pathology, Bacteriology, Gynecology), Animal (Cat, Dog, Horse, Cattle), End User, Region-Global Forecast to 2025

“The global veterinary point-of-care diagnostics market is projected to grow at a CAGR of 8.9% during the forecast year.” The global veterinary point-of-care diagnostics market size is projected to reach USD 2.4 billion by 2025 from USD 1.4 billion in 2019, at a CAGR of 8.9%. The increasing prevalence of zoonotic diseases among companion and livestock animals and the growing need for rapid disease detection are the major factors driving the growth of this market. However, the high cost of veterinary imaging instruments is expected to restrain market growth to a certain extent. “The consumables segment dominates the veterinary point-of-care diagnostics market.” Based on product, the veterinary point-of-care diagnostics market is segmented into consumables and instruments. C......
$5650

Veterinary Monitoring Equipment Market by Type (Vital Signs Monitor, Anesthesia Monitor, ECG Monitor), Target Area (Respiratory diseases, Weight Monitoring), Animal Type (Dogs, Cats, Equines), End User (Veterinary Clinic), Region – Global Forecast to 2025

“The veterinary monitoring equipment market is projected to grow at a CAGR of 9.8% during the forecast period (2019–2025).” The veterinary monitoring equipment market is projected to reach USD 570 million by 2025 from USD 326 million in 2019, at a CAGR of 9.8%. The increasing focus on animal health among pet owners and the growing prevalence of diseases among companion animals are the key factors driving market growth. Also, the growing companion animal population, rising demand for pet insurance, growing animal health expenditure, and the rising number of veterinary practitioners & income levels in developed economies are aiding the adoption of veterinary monitoring equipment. “The vital sign monitors segment is expected to grow at the highest rate during the forecast pe......
$5650

Medical Wearables Market by Device (Vital Signs Monitoring, Blood Pressure Monitor, Glucose Monitor, ECG Monitor, Pulse Oximeter), Product (Smartwatch, Patches, Wristbands), End User (Hospitals, Nursing Homes, Ambulatory) – Global Forecast to 2025

“The medical wearables market is expected to grow at a CAGR of 21.4% during the forecast period.” The global medical wearables market is projected to reach USD 19.5 billion by 2025 from USD 7.4 billion in 2020, at a high CAGR of 21.4% during the forecast period of 2020 to 2025. The growing adoption of smartphones, increasing penetration of 3G/4G networks, growing geriatric population and rising focus on patient-centric healthcare delivery. “Based on device type, the vital signs monitoring segment accounted for the largest share of the market in 2019.” In 2019, the vital signs monitoring segment accounted for the largest share of the Clinical-Grade market. The large share of this segment can be attributed to the growing use of high-tech devices, which are compact, user-fri......
$5650

Stoma/Ostomy Care Market by Product (Bags (Surgery Type (Ileostomy, Colostomy, Urostomy), System (One, Two-Piece), Usability (Drainable, Closed), Shape (Flat, Convex)), Accessories (Powder, Deodorant)), End User and Region – Global Forecast to 2025

“The ostomy care market projected to grow at a CAGR of 4.4% over the forecast period of 2020-2025.” The ostomy care market is projected to reach USD 3.5 billion by 2025 from USD 2.8 billion in 2020, at a CAGR of 4.4% during the forecast period. Globally, the population of individuals aged 60 years and above is expected to increase from 962 million in 2017 to 2.1 billion by 2050 (Source: UN Population Division). The rising geriatric population is considered as one of the major factors driving the growth of the ostomy care industry, as the incidence of bladder cancer and colorectal cancer is high among geriatric individuals. Thus, the rising geriatric population, coupled withthe growing number of awareness programs to educate patients regarding the use of ostomy products,are the major......
$6780

Healthcare / Medical Simulation Market by Product & Services (Patient Simulator, Task Trainer, Surgical Simulator (Laparoscopy, Arthroscopy), Dental Simulator, Eye Simulator, Ultrasound Simulator, Simulation Software), End User – Global Forecast to 2025

“The medical simulation market is projected to grow at a CAGR of 14.6% between 2020 and 2025.” The global medical simulation market size is expected to reach USD 3.7 billion by 2025 from USD 1.9 billion in 2020, at a CAGR of 14.6% from 2020 to 2025. The limited access to live patients during training, advancements in medical education, increasing demand for minimally invasive treatments, increasing focus on patient safety, and growing demand for virtual training due to current COVID-19 pandemic are the major factors driving the growth of the medical simulation industry. Moreover, factors such as increasing awareness about simulation education in emerging countries and shortage of healthcare personnel are creating lucrative opportunities for the market players. “Laparoscopic sur......
$4950

Microfluidics Market by Product (Devices, Components (Chips, Sensors, Pump, Valves, and Needles), Application (IVD [POC, Clinical, Veterinary], Research, Manufacturing, Therapeutics), End User and Region – Global Forecast to 2025

“The microfluidics market is projected to grow at a CAGR of 22.9%.” The global microfluidics market size is projected to reach USD 44.0 billion by 2025 from USD 15.7 billion in 2020, at a CAGR of 22.9% during the forecast period. The ability of the microfluidics technology to replicate all the functions of its traditional counterparts in various healthcare applications, such as drug delivery, point-of-care (POC) diagnostics, and clinical diagnostics, is resulting in its wider adoption across the globe. In addition to this, technological advancements, increasing focus on data precision & accuracy, fast returns on investment, and faster testing & improved portability through microfluidic chip miniaturization are driving growth of the microfluidics industry. “In 2019, in-v......
$4950

Tissue Diagnostics Market by Product (Antibodies, Kits, Slide Staining System, Tissue Processing System), Technology (ISH, IHC, Special Staining), Disease (Breast Cancer, NSCLC, Lymphoma), End User (Hospitals, Research Laboratories)-Global Forecast to 2025

“The global tissue diagnostic market size is projected to register a CAGR of 6.5% during the forecast period.” The global tissue diagnostics market is expected to reach USD 4.7 billion by 2025 from USD 3.4 billion in 2020, at a CAGR of 6.5%. The growth in this market is driven by rising incidence of cancer, developing infrastructure for cancer diagnosis, the recommendation of cancer screening, availability of reimbursements, and increasing healthcare expenditure. “The consumables segment is anticipated to grow at the fastest growth rate during the forecast period” Based on product type, the tissue diagnostics market is segmented into instruments and consumables. The consumables segment is expected to grow at the highest growth rate during the forecast period. The large mar......
$4950

Biofilms Treatment Market by Products (Debridement Equipment, Gauze, Dressing, Gel, Ointment), Wound Type (Traumatic, Surgical, Open, Diabetic Foot, Venous Leg Ulcer & Burns), End User (Hospital, ASCs, Wound Care Centers, Homecare)-Global Forecast to 2025

“Rising incidence of burn injuries is driving the growth of the biofilms treatment market” The biofilms treatment market is projected to reach USD 2.4 billion by 2025 from USD 1.6 billion in 2020, at a CAGR of 7.9%. The growth of this market is majorly driven by the rising prevalence of chronic, surgical, and traumatic wounds and the increasing incidence of burn injuries. However, the high cost and low adoption rate of advanced wound care products are expected to limit the growth of this market to a certain extent. “Gauzes and dressings segment accounted for the largest share of the biofilms treatment market in 2019” Based on product, the biofilms treatment market is segmented into debridement equipment; gauzes and dressings; gels, ointments, and sprays; wipes, pads, and l......
$5650
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy